Rates of major bleeding and intracranial hemorrhage are similar for apixaban and dabigatran versus aspirin, while rates are ...

A systematic review and meta-analysis of nine trials comparing non-vitamin K oral anticoagulants with low-dose aspirin ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

Major bleeding was low overall, but the findings align with other large datasets showing greater risk with rivaroxaban.

Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

Patients were included in the study cohort (ie, the combination-therapy cohort) if they self-reported aspirin use and/or had purchased prescription antiplatelet medication from a KPCO pharmacy ...

In a systematic review and meta-analysis of trials of non-vitamin K oral anticoagulants vs. single antiplatelet therapy, ...

Background Differences in the clinical outcomes and level of risk among Asian versus non-Asian patients with atrial ...

Compared with rivaroxaban, abelacimab is associated with fewer bleeding events in patients with AF and moderate to high risk for stroke.

Kyprolis can interact with anticoagulants and antiplatelets, which are prescribed to treat and help prevent blood clots. Kyprolis, as well as antiplatelets and anticoagulants, increases your risk ...